Nonetheless, the concordant results observed in GSE10846 and GSE32918 indicate that high SPIB and low BATF expression can identify a subgroup of ABC-DLBCL cases with good outcome, which in the context of our U.K. population-based cohort includes a small subset of ABC-DLBCL cases treated with R-CHOP displaying 5 year or greater survival. The gene discussed is SPIB; the disease is diffuse large B-cell lymphoma.